Total Assets
2026$56.28B
Total Revenue
2026$6.96B
Net Income
2026$2.02B
Operating Cash Flow
2026$2.54B
549300WTZWR07K8MNV44ACTIVE100% match confidenceUS-DE
Identity
Legal Address
C/O THE CORPORATION TRUST COMPANYCORPORATION TRUST CENTER
WILMINGTON, US-DE
19801 US
Category
GENERAL
Registration
- Status
- ISSUED
- Initial
- Dec 11, 2012
- Next Renewal
- Mar 21, 2027
- Managing LOU
- 5493001KJTIIGC8Y1R12
Corporate Structure
This Entity
GILEAD SCIENCES, INC.
549300WT…
1 Direct Subsidiary
Suppliers & Competitors Referencing This Company
1 appearanceTracked companies that reference this legal entity (or a subsidiary rolled up to it) in their supply chain or competitive landscape filings.
| Company | Role | Tier | Filing Year |
|---|---|---|---|
| Merck & Co., Inc.MRK | Partners With | — | 2025 |